From amounts available in Title IV under the heading Research, Development, Test and Evaluation, Army, up to $1,000,000 may be available for Recombinant Activated Factor VII.

1. Adds Sec. __. (a) Blast Injury Prevention, Mitigation, and Treatment Initiative of the Army.--Of the amount appropriated by title IX under the heading "Research, Development, Test, and Evaluation, Army", up to the amounts as follows may be available for programs and activities relating to the blast injury prevention, mitigation, and treatment initiative: wherever appropriate

   Adds a section

   Inserted: Sec. __. (a) Blast Injury Prevention, Mitigation, and Treatment Initiative of the Army.--Of the amount appropriated by title IX under the heading "Research, Development, Test, and Evaluation, Army", up to the amounts as follows may be available for programs and activities relating to the blast injury prevention, mitigation, and treatment initiative:

   Inserted: (1) $1,000,000 for Program Element #62787A for characterization of armor for blast, ballistic, and fire protection.

   Inserted: (2) $1,000,000 for Program Element #63002A for far forward use of recombinant activated factor VII.

   Inserted: (3) $1,000,000 for Program Element #63002A for warfighter face, eye, and ear protection.

   Inserted: (4) $1,000,000 for Program Element #63807A for extended shelf life of red blood cells.

   Inserted: (b) Blast Injury Prevention, Mitigation, and Treatment Initiative of the Navy.--Of the amount appropriated by title IX under the heading "Research, Development, Test, and Evaluation, Navy", up to $1,000,000 may be made available for the blast injury prevention, mitigation, and treatment initiative for Program Element #62131m for combat headborne system research.

   The amendment doesn't say where this goes; the clerk decides.

   Original wording

   At the appropriate place, insert the following:

Read automatically from the Congressional Record. Check the original before relying on it.

As printed